0000899243-19-016441.txt : 20190611 0000899243-19-016441.hdr.sgml : 20190611 20190611181009 ACCESSION NUMBER: 0000899243-19-016441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190607 FILED AS OF DATE: 20190611 DATE AS OF CHANGE: 20190611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cima Michael J. CENTRAL INDEX KEY: 0001615992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 19892010 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-07 0 0001492674 T2 Biosystems, Inc. TTOO 0001615992 Cima Michael J. 101 HARTWELL AVE LEXINGTON MA 02421 1 0 0 0 Common Stock 2019-06-08 4 M 0 9000 A 216418 D Restricted Stock Units 2019-06-08 4 M 0 9000 0.00 A Common Stock 9000 9000 D Stock Option (Right to Buy) 1.54 2019-06-07 4 A 0 22000 0.00 A 2029-06-07 Common Stock 22000 22000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On June 8, 2018 the reporting person was granted 9,000 restricted stock units that vested on June 8, 2019. The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 7, 2019. /s/ John Sprague, Attorney-in-fact 2019-06-11